bioAffinity Technologies ...

0.26
-0.01 (-3.88%)
At close: Mar 28, 2025, 3:59 PM
0.27
3.70%
After-hours: Mar 28, 2025, 05:31 PM EDT

bioAffinity Ratios Statement

Year FY23 FY22 FY21 FY20 FY19
PE Ratio -1.62 -0.88 -9.68 -8.42 -18.51
PEG Ratio 0.03 -0.01 0.74 -0.07 n/a
PS Ratio 5.08 1.5K n/a n/a n/a
PB Ratio 2.65 0.65 -3.88 -4.06 -15.17
P/FCF Ratio -2.12 -1.68 -29.89 -27.7 -24.48
P/OCF Ratio -2.13 -1.77 -29.89 -27.74 -24.59
OCF/S Ratio -2.38 -847.56 n/a n/a n/a
Debt / Equity Ratio 0.33 0.02 -0.72 -0.66 -0.99
Quick Ratio 1.76 10.50 0.10 0.01 0.13
Current Ratio 1.77 10.50 0.11 0.01 0.13
Asset Turnover 0.31 0.00 n/a n/a n/a
Interest Coverage -214.77 -1.58 -2.2 -6.81 -14.39
Return on Equity (ROE) -1.63 -0.74 0.40 0.48 0.82
Return on Assets (ROA) -0.97 -0.67 -4.35 -49.92 -5.02
Return on Capital (ROIC) -1.33 -0.36 0.19 0.24 0.77
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin 31.26% 90.28% n/a n/a n/a
Net Profit Margin -313.41% -169.77K% n/a n/a n/a
Pretax Profit Margin -312.58% -169.72K% n/a n/a n/a
Operating Profit Margin -314.84% -83.51K% n/a n/a n/a
FCF Margin -239.32% -89.34K% n/a n/a n/a
EBITDA Margin -301.26% -116.78K% n/a n/a n/a